Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C)

[Edit]

CD263; TNFRSF10-C; DCR1; LIT; TRAILR3; TRID; Decoy Receptor 1; Tnf-Related Apoptosis-Inducing Ligand Receptor 3; Trail Receptor Without An Intracellular Domain

Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C)

TRAILR3, a novel member of the TRAIL receptor family. Although the open reading frame potentially encoded a 299-amino acid protein, the authors suggested that translation begins at amino acid 41, yielding a protein of 259 amino acids. TRAILR3 contains a predicted signal sequence, 2 of the 4 cysteine-rich pseudorepeats characteristic of the extracellular domain of members of the TNF receptor family, an extracellular linker sequence, and a short, hydrophobic C-terminal sequence. Transient expression studies showed that TRAILR3 is a plasma membrane-bound protein capable of high affinity interaction with the TRAIL ligand. In contrast to TRAILR1 and TRAILR2, TRAILR3 appears to be glycosylphosphatidylinositol-linked and lacks a cytoplasmic region, including the death domain.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA137Hu01 Recombinant Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA137Hu01 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) WB; IHC; ICC; IP.
MAA137Hu21 Monoclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) WB
MAA137Hu22 Monoclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) WB; IHC; ICC; IP.
Assay Kits SEA137Hu ELISA Kit for Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL."J. Biol. Chem. 272:25417-25420(1997) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family."J. Exp. Med. 186:1165-1170(1997) [PubMed] [Europe PMC] [Abstract]
  3. "An antagonist decoy receptor and a death domain-containing receptor for TRAIL."Science 277:815-818(1997) [PubMed] [Europe PMC] [Abstract]
  4. "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors."Science 277:818-821(1997) [PubMed] [Europe PMC] [Abstract]
  5. "Characterization of two receptors for TRAIL."FEBS Lett. 416:329-334(1997) [PubMed] [Europe PMC] [Abstract]
  6. "Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL."J. Immunol. 160:3-6(1998) [PubMed] [Europe PMC] [Abstract]
  7. "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract]
  8. "DNA sequence and analysis of human chromosome 8." Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]
  9. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  10. "Signal peptide prediction based on analysis of experimentally verified cleavage sites."Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract]